FATE

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Fate Therapeutics (FATE) Earnings Date & Reports

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

FATE is expected to report earnings to rise 20.56% to -38 cents per share on July 30

Fate Therapeutics FATE Stock Earnings Reports

Q2'25

Est.

$-0.39

Q1'25

Beat

by $0.07

Q4'24

Est.

$-0.44

Q3'24

Beat

by $0.02

Q2'24

Beat

by $0.13

The last earnings report on May 13 showed earnings per share of -31 cents, beating the estimate of -38 cents. With 3.20M shares outstanding, the current market capitalization sits at 139.85M.

View a ticker or compare two or three

Compare

FATE

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For FATE
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a clinical stage biopharmaceutical company

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

12278 Scripps Summit Drive

Phone

+1 858 875-1800

Employees

220

Web

https://www.fatetherapeutics.com